$INSM
Price history, market instrument context, member research, and related headlines in one place.
INSM key statistics
NasdaqGSUSD
52-week range
$90.397%$212.75
Latest session $97.90–$100.72Insmed Incorporated (INSM) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $99.21, up $1.42 (1.45%) from the previous close of $97.79. It has traded between $97.90 and $100.72 in the latest session. Over the past year it has ranged from $90.39 to $212.75, leaving it in the lower quarter of its 52-week range (7%). Reported volume for the session was 3.3M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Insmed CMO Martina Flammer sells $3.49m in company stock — See source for full details.
Insmed surges on raised Brinsupri sales forecast, Q2 beats — See source for full details.
Insmed stock led a biotech rally Thursday, catapulting more than 30% on solid second-quarter sales for its new lung disease drug.
Insmed earnings up next: Can Brinsupri hit $285M in Q2? — See source for full details.
Here’s Why Baron Health Care Fund Remains Bullish on Insmed (INSM) — See source for full details.
Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter is available to download here. Mid-cap stocks delivered strong results, with the Russell Midcap® Growth Index rising 14.55% and slightly outperforming the Russell Midcap® Value Index’s 13.40% gain. Information […]
Loading $INSM research…